WellAlly Logo
WellAlly康心伴
Business Plan

Transform Life Data Into Inheritable Digital Assets

Save Future Generations' Lives, Drive Sustainable Medical Research
Each life's end is accompanied by the disappearance of $10,000+ worth of health data. We're reconstructing this $600 billion value chain.

Funding Request (Seed Round)
$30万
@ $300万 Pre-money
Market Size (TAM)
$600B+
全球每年消逝数据价值
Expected Return
20-50x
$60M+ 退出预期

Pain Point: Data Disappears with Life

100% of health data disappears at death, representing a huge resource waste

Children inherit their parents' genes but cannot inherit their parents' 'health lessons' and data insights

Medical researchers cannot obtain complete, cross-lifecycle longitudinal data

The annual medical R&D value loss due to data fragmentation exceeds $600 billion

Solution: Data Assetization (HDA)

Health-NFT: Digital asset carrier that lasts longer than users' lives

Smart contract inheritance: Automated data inheritance protocol based on 3 major public chains

Perpetual AI royalties: Families can receive permanent royalty streams after data trains models

Research trading market: Decentralized data trading, ensuring privacy and revenue rights

Market Drivers

Why Now?

Aging Society

By 2050, the global population aged 65+ will reach 1.5 billion

Pharma Data Crisis

New drug R&D costs $2.6 billion, with a 90% failure rate

NFT Popularization

Over 40 million people worldwide hold digital assets

Regulatory Support

GDPR and the 21st Century Cures Act support data rights confirmation

Product Architecture: Three Inheritance Chains

We structure scattered data into tradable, inheritable NFT asset packages

Family Legacy Chain

Family Inheritance Chain

Let children inherit parents' health insights

  • Genetic risk intelligent analysis
  • Disease progression timeline retrospection
  • Drug reaction history archives
  • Encrypted access control

Research Legacy Chain

Research Inheritance Chain

Anonymized data contributed to scientific research

  • Longitudinal lifecycle data
  • Real World Evidence (RWE)
  • Disease modeling data sources
  • Clinical trial optimization

Model Legacy Chain

Model Rights Chain

Passive income that can still be generated after death

  • AI model training authorization
  • Smart contract automatic profit sharing
  • Transparent data usage tracking
  • Automatic beneficiary inheritance

Business Model

Diversified revenue sources, from subscription services to asset trading commissions

ToC (Consumer)

$150万Year 3 预期
  • 10K subscriber target
  • Family Guardian Package
  • Low churn rate (<8%)
  • High switching costs

ToB (Pharma/Research)

$180万Year 3 预期
  • 10+ enterprise contracts
  • Specialty hospital partnerships
  • Academic medical center licensing
  • Multi-year licensing agreements

ToD (Token Economy)

$20万Year 3 预期
  • 20+ AI model deployments
  • Smart contract automation
  • Perpetual royalty stream
  • Token deflationary model

Five-Year Financial Forecast

Year 3 as Critical Inflection Point

MetricsYear 1Year 2Year 3Year 4Year 5
C 端用户数5002,50010,00040,000150,000
C 端收入$5万$30万$150万$600万$2,000万
B 端合约数151540100
B 端收入$2万$20万$180万$500万$1,200万
Token/模型收入$0$5万$20万$80万$300万
总营收$7万$55万$350万$1,180万$3,500万
净利润率-150%-50%+10%+20%+30%

竞争壁垒 (Moats)

数据网络效应

用户越多 → 模型越准 → 价值越高,无法复制的正向循环

专利结构化技术

5年技术壁垒:将体感、病理、基因多模态数据结构化

Web3 基础设施

合法合规的智能合约继承体系,比竞争对手快 3-5 年

顶级科学顾问

全球 Top 10 长寿学家与伦理学家背书

路线图 (Go-to-Market)

Phase 1
0-6 Months
Trusted Launch
Target
10K 核心用户
Phase 2
6-18 Months
Vertical Expansion
Target
10万+ 疾病垂类用户
Phase 3
18-36 Months
Mainstream
Target
100万+ 大众富裕阶层
Phase 4
36+ Months
Global Scale
Target
1000万+ 全球用户

共同定义健康数据资产类别

Seed Round 融资开放中: $30万 @ $300万 Valuation